Top Markets
#1 DogBull DogBull +105.13%
#2 Siacoin Siacoin +54.09%
#3 ADO Protocol ADO Protocol +46.53%
#4 MarsCoin MarsCoin +44.60%
#5 UnifAI Network UnifAI Network +44.55%
#6 Useless Coin Useless Coin +23.36%
#7 Magma Finance Magma Finance +22.74%
#8 Ontology Gas Ontology Gas +22.45%
#9 Apertum Apertum +14.61%
#10 Filecoin Filecoin +13.89%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Turn Therapeutics Inc. Turn Therapeutics Inc.

Turn Therapeutics Inc.

TTRX
Rank in Stocks #16355
Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a... Turn Therapeutics Inc., officially known as Global Health Solutions, Inc., is a pharmaceutical enterprise dedicated to developing treatments for conditions affecting the skin, nails, and eyes. The company utilizes a proprietary drug delivery system engineered to effectively permeate skin and nail tissues. This advanced technology is integrated into their solutions for both acute and chronic wound care, specifically designed to help combat antibiotic resistance. Consequently, these products empower healthcare institutions to effectively manage a broad spectrum of dermatological challenges, encompassing everything from sudden injuries and persistent wounds to general skin ailments and specific dermatoses. Global Health Solutions, Inc. was established in 2015 and maintains its headquarters in Westlake Village, California.
Share Price
$10.01
Market Cap
$298.09M
Change (1 day)
4.24%
Change (1 year)
-
Country
US
Trade Turn Therapeutics Inc. (TTRX)

Category

Healthcare
Revenue for Turn Therapeutics Inc. (TTRX)
Revenue in Sep 2026 TTM: 0
According to Turn Therapeutics Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Turn Therapeutics Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH